Filing Details
- Accession Number:
- 0001127602-21-004268
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-08 10:18:49
- Reporting Period:
- 2021-02-05
- Accepted Time:
- 2021-02-08 10:18:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 794172 | Meridian Bioscience Inc | VIVO | In Vitro & In Vivo Diagnostic Substances (2835) | 310888197 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1719325 | P. John Kenny | 3471 River Hills Drive Cincinnati OH 45244 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-05 | 20,000 | $25.00 | 274,330 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-05 | 20,000 | $25.00 | 254,330 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 15, 2020.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 9, 2020.
Billionaire Hedge Funds
